In addition, we found that imatinib, which is effective in FIP1L1-PDGFRalpha rearrangement positive hypereosinophilic syndromes [11], was highly effective also in cases bearing this KITM541L variant. The gene discussed is FIP1L1; the disease is hypereosinophilic syndrome.